The numbers that were included in the budget did not break down into that separation. These are all new realities that we are facing.
There is a lot of work going on with Health Canada, including in respect to drugs that may be approved in the future, with the DIN numbers. The government has announced in the budget that it will be examining options for establishing, potentially, a rebate program to retroactively reimburse Canadians using cannabis for medical purposes, an amount that would be in recognition of the federal portion of the excise duty that may be imposed on equivalent products before the completion of the program. There is still work that is being undertaken in this area by the government.
In terms of a specific analysis with Health Canada, there is no number that I have in my possession that I could provide a comment on today.